| scholarly article | Q13442814 |
| P356 | DOI | 10.3233/CBM-160255 |
| P8608 | Fatcat ID | release_534tovs6bfeq3c7qcsawfnsae4 |
| P698 | PubMed publication ID | 28009325 |
| P2093 | author name string | Nengtai Ouyang | |
| Kai Huang | |||
| Xiaojuan Li | |||
| Yue Zhu | |||
| Xinzhi Peng | |||
| Haibo Chen | |||
| Shaojian Lin | |||
| Dingyuan Luo | |||
| Mingqing Huang | |||
| Langping Tan | |||
| Zhibo Chen | |||
| Honghao Li | |||
| Miaoyun Long | |||
| Penghui Lu | |||
| P2860 | cites work | Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis | Q38928339 |
| A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis | Q38995509 | ||
| Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma | Q39675729 | ||
| YKL-40, a secreted glycoprotein, promotes tumor angiogenesis | Q39797155 | ||
| Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer | Q43011817 | ||
| CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells. | Q43053159 | ||
| Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. | Q44559401 | ||
| Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma | Q46926442 | ||
| YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma | Q48904499 | ||
| Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma. | Q51068196 | ||
| A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior. | Q54606008 | ||
| Integrated genomic characterization of papillary thyroid carcinoma | Q28251986 | ||
| Tumour-educated macrophages promote tumour progression and metastasis | Q29614307 | ||
| Serum YKL-40 level is associated with the chemotherapy response and prognosis of patients with small cell lung cancer | Q33573132 | ||
| Gene expression in papillary thyroid carcinoma reveals highly consistent profiles | Q33952877 | ||
| Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells | Q34052057 | ||
| Serum YKL-40 independently predicts outcome after transcatheter arterial chemoembolization of hepatocellular carcinoma | Q34412656 | ||
| Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers | Q35527112 | ||
| YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer | Q35746711 | ||
| Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model | Q35783730 | ||
| Role of infiltrated leucocytes in tumour growth and spread | Q35784552 | ||
| Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer | Q35791353 | ||
| Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression | Q35835003 | ||
| Prognostic and predictive value of YKL-40 in stage IIB-III melanoma | Q35989186 | ||
| YKL-40 expression in soft-tissue sarcomas and atypical lipomatous tumors. An immunohistochemical study of 49 tumors | Q37667188 | ||
| Thyroid cancer epidemiology and prognostic variables | Q37772326 | ||
| BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer | Q38039906 | ||
| Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival | Q38424345 | ||
| YKL-40/CHI3L1 drives inflammation on the road of tumor progression | Q38574540 | ||
| Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients? | Q38852978 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 273-284 | |
| P577 | publication date | 2016-12-16 | |
| P1433 | published in | Cancer Biomarkers | Q2051879 |
| P1476 | title | CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma | |
| P478 | volume | 18 |
| Q99417962 | Chitinase-3 like-protein-1 function and its role in diseases |
| Q49359637 | Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher Disease. |
| Q91123473 | High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder |
| Q61796607 | Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs) |
| Q47139075 | Inflammation related genes are upregulated in surgical margins of advanced stage oral squamous cell carcinoma. |
| Q89538443 | LINC00963 Promotes Ovarian Cancer Proliferation, Migration and EMT via the miR-378g /CHI3L1 Axis |
| Q92761481 | MetaOmGraph: a workbench for interactive exploratory data analysis of large expression datasets |
| Q33596910 | Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients |
Search more.